Vimarsana
Biggest News Aggregation in the World

Targets Ther News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Targets Ther. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Targets Ther Today - Breaking & Trending Today

AAD Reading Room | A Clinical Guide to Comorbidities in Psoriasis - Vimarsana News

AAD Reading Room | A Clinical Guide to Comorbidities in Psoriasis

Psoriasis is associated with a range of comorbidities. But while these comorbidities are well-known, many still go overlooked and are underdiagnosed.

BeiGene Presents Results from Phase 3 Trial of Tislelizumab in Nasopharyngeal Cancer at ESMO Immuno-Oncology Congress 2021 - Vimarsana News

BeiGene Presents Results from Phase 3 Trial of Tislelizumab in Nasopharyngeal Cancer at ESMO Immuno-Oncology Congress 2021

In RATIONALE 309, tislelizumab in combination with chemotherapy significantly prolonged progression-free survival for patients, with survival benefit observed across patient subgroups The safety

Daiichi Sankyo Company, Limited: Patritumab Deruxtecan Data at ASCO Demonstrates Tumor Response Across Multiple Resistance Mechanisms in Patients with Advanced EGFR-Mutated NSCLC - Vimarsana News

Daiichi Sankyo Company, Limited: Patritumab Deruxtecan Data at ASCO Demonstrates Tumor Response Across Multiple Resistance Mechanisms in Patients with Advanced EGFR-Mutated NSCLC

Oral presentation highlighting extended follow-up data from phase 1 study in patients with locally advanced or metastatic TKI-resistant, EGFR-mutated NSCLC shows promising clinical activity Data